v3.25.4
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Dec. 31, 2025
Mar. 31, 2025
Current assets:    
Cash and cash equivalents $ 9,934 $ 9,136
Other current assets 257 473
Total current assets 10,191 9,609
Noncurrent assets:    
Property and equipment, net 20 21
Deferred offering costs 0 176
Total noncurrent assets 20 197
Total Assets 10,211 9,806
Current liabilities:    
Accounts payable 714 676
Accrued expenses 936 1,031
Total current liabilities 1,650 1,707
Total Liabilities 1,650 1,707
Commitments and contingencies (Note 4)
Stockholders' equity:    
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2025 and March 31, 2025, respectively 0 0
Common stock, $0.001 par value, 500,000,000 shares authorized, 11,409,344 and 2,497,033 shares issued and outstanding as of December 31, 2025 and March 31, 2025, respectively 11 2
Additional paid-in capital 72,977 58,476
Accumulated deficit (64,427) (50,379)
Total Stockholders' Equity 8,561 8,099
Total Liabilities and Stockholders' Equity $ 10,211 $ 9,806